Cite
HARVARD Citation
Kabbani, D. et al. (2019). High incidence of clinically significant cytomegalovirus infection in CMV D+/R+ lung transplant recipients receiving 3 months of antiviral prophylaxis. Transplant infectious disease. 21 (4), p. n/a. [Online].